An observational study in Acute Kidney Injuries, Quality of Life and Chronic Kidney Disease, sponsored by University Hospital, Clermont-Ferrand. Completed at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-17.
Sponsored by University Hospital, Clermont-Ferrand · Observational
Soum E, Timsit JF, Ruckly S, Gruson D, Canet E, Klouche K, Argaud L, Garrouste-Orgeas M, Mariat C, Vincent F, Cayot S, Darmon M, Bohe J, Schwebel C, Bouadma L,…PubMed 36447221 ↗
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 154 studies in Acute Kidney Injury with a site in France — 31 open to participants now, 35 under way, 4 of them phase 3. Acute Kidney Injury · France.
Among the 154 studies in Acute Kidney Injury with a site in France, this one is the 30th largest by enrollment of the 76 observational ones that give a count, is one of 7 that started in 2017, is one of 76 observational ones, and was the 48th registered.
1,693 studies on the registry are indexed under Acute Kidney Injury; 392 are open to participants now.
Browse Acute Kidney Injury studies →31 of the 154 studies in Acute Kidney Injury with a site in France are open now. Recruiting first, the newest first:
Centre Hospitalier Universitaire de Nīmes · Sites in France
Ages 18+
Uppsala University · Sites in France, Australia, Brazil and 7 more countries
Ages 0–16
AstraZeneca · Sites in France, United States, Argentina and 11 more countries
Ages 18–80
Hospices Civils de Lyon · Sites in France
Ages 18+
University Hospital, Bordeaux · Sites in France
Ages 18+
A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →
Of the 229 Acute Kidney Injury studies recruiting now, 161 (70%) set no upper age limit and 35 (15%) stop at 75 or younger; 22 take children under 18; 25 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
154 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 11 · Phase 3 22 · Phase 4 5
First in 2004; this study’s year is marked. 7 started in 2017.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 287 is above the median of 160 across 814 observational studies indexed under Acute Kidney Injury.
Median enrollment 150 across the 78 interventional studies, 190 across the 76 observational. Of the 106 that completed or were terminated, 8 (8%) have results posted.
This tab as a report to print or save as PDF → With an account.
13 of 154 have an industry lead sponsor. The 10 most frequent:
University Hospital, Clermont-Ferrand is the lead sponsor of 859 studies on the registry; 177 are open to participants now.
University Hospital, Clermont-Ferrand has 4 studies filed under Acute Kidney Injury — fewer than ten, so there is no comparison to draw.
11 of the studies in Acute Kidney Injury with a site in France that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT03329313University Hospital, MontpellierEffects of Variation of Sodium Dialysate in ICU | 2026-12-19 |
| NCT06823115Indiana UniversityAssessment of Worldwide Acute Kidney Injury Epidemiology in Neonates 2.0 | 2027-01 |
| NCT04264065Assistance Publique - Hôpitaux de ParisAlbumin and Prognosis of Severely Patients Burns | 2027-01-16 |
| NCT07215702AstraZenecaA Study to Investigate the Efficacy, Safety, and Tolerability of AZD4144in Participants With Sepsis-associated Acute Kidney Injury. | 2027-02-11 |
| NCT07596407Assistance Publique - Hôpitaux de ParisAcute Kidney Injury : Long-term Renal and Cardiovascular Prognosis and Biomarker-based Risk Assessment | 2027-05-30 |
Add all 11 to your calendar (.ics) → With an account.
Among the 154 studies in Acute Kidney Injury with a site in France, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Acute kidney injury (AKI) involves poor prognosis in ICU patients. The renal prognosis at long term is unknown.
The study will determine chronic kidney injury incidence and quality of life, five years after AK during ICU stay.
Prospective study. All patients who participated ELVIS study (clinical trials: 00875069) can be enrolled in SURIA.
Patients are contacted by telephone. Investigator delivery objective and honest information. If patients accepts the study, answers will be collected.
Collected data are: creatinine serum, two surveys (quality of life and activities of daily living), date of onset of renal replacement therapy.
ICU patients
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
ICU Patients included in ELVIS study, AKI requiring renal replacement therapy Length of ICU stay ≥ 48h
Exclusion Criteria:
Pregnant or nursing woman's job
incidence of chronic kidney disease
incidence of chronic kidney disease in patients who had an acute kidney injury during their ICU stay and requiring an renal replacement therapy
Time frame: 5 years after the first acute kidney injury requiring renal replacement therapy
severity of CKD according to the International Classification of Chronic Kidney Disease
Kidney function will be measured by creatinine serum or chronic dialysis or kidney transplantation
Time frame: 5 years after the first acute kidney injury requiring renal replacement therapy
impact of the renal replacement therapy on long-term renal function
Intermittent or continuous renal replacement therapy. Data collected in the database from ELVIS study. Kidney function will be measured by creatinine serum or chronic dialysis
Time frame: 5 years after the first acute kidney injury requiring renal replacement therapy
quality of life
Quality of life will be assessed with the Q5D score
Time frame: 5 years after the first acute kidney injury requiring renal replacement therapy
Activities of daily living
Activities of daily living will be assessed with the Katz adjustment scales
Time frame: 5 years after the first acute kidney injury requiring renal replacement therapy
Mortality
Mortality
Time frame: 5 years after the first acute kidney injury requiring renal replacement therapy
Ran from Sep 2017 to primary completion in Sep 2018, 12 months.
Of 350 non-industry observational studies under Acute Kidney Injury, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 42. This study's 12 months is below that.
Counting every sponsor, half of 365 studies reached it within 24 months; a quarter within 12 and three quarters within 42.
Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 17, 2026: primary completion Dec 2017 → Sep 2018 and completion Dec 2017 → Dec 2018.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
Soum E, Timsit JF, Ruckly S, Gruson D, Canet E, Klouche K, Argaud L, Garrouste-Orgeas M, Mariat C, Vincent F, Cayot S, Darmon M, Bohe J, Schwebel C, Bouadma L,…PubMed 36447221 ↗
Soum E, Timsit JF, Ruckly S, Gruson D, Canet E, Klouche K, Argaud L, Garrouste-Orgeas M, Mariat C, Vincent F, Cayot S, Darmon M, Bohe J, Schwebel C, Bouadma L,…PubMed 36447221 ↗
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Oct 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital, Clermont-Ferrand →